Edition:
United States

People: Aldeyra Therapeutics Inc (ALDX.A)

ALDX.A on American Stock Exchange

5.29USD
22 Jul 2019
Change (% chg)

$0.02 (+0.38%)
Prev Close
$5.27
Open
$5.14
Day's High
$5.29
Day's Low
$5.14
Volume
200
Avg. Vol
492
52-wk High
$16.55
52-wk Low
$5.01

Clark, David 

Dr. David J. Clark M.D., is Chief Medical Officer of the Company. Dr. Clark has served as Chief Medical Officer since January 2016. He has approximately 19 years of global industry experience in both pharmaceutical firms and biotechnology companies based in the United States and Europe. Prior to joining Aldeyra, Dr. Clark served as the Chief Medical Officer of Wilson Therapeutics, a privately-held biotechnology company developing novel pharmaceuticals to treat Wilson Disease, a rare autosomal recessive disorder of copper metabolism, from 2013 to 2015. Prior to that, from September 2011 to February 2013, he served as the Senior Vice President of Translational Medicine of TransTech Pharma, LLC, a privately held pharmaceutical company focused on the discovery and development of human therapeutics across a wide range of indications in several therapeutic areas, including metabolic, neuroscience, respiratory, ophthalmology and oncology. Previously, he held the role of Chief Medical Officer at NormOxys Inc., a privately held biotechnology company focused on the development of a new class of small molecule drugs for the treatment of oncology, cardiovascular and neuroscience indications. Dr. Clark has also held clinical leadership positions at Pfizer Inc. from 2001 to 2009 and at GlaxoSmithKline plc from 1997 to 2001. Dr. Clark received his medical degree from the University of Edinburgh, trained in internal medicine and conducted respiratory medicine academic research in the UK before moving into pharmaceutical industry research.

Basic Compensation

Total Annual Compensation, USD 376,250
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD 133,525
All Other, USD 594,999
Fiscal Year Total, USD 1,104,770

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --